Broadwood Capital Inc 13F annual report
Broadwood Capital Inc is an investment fund managing more than $867 million ran by Neal Bradsher. There are currently 7 companies in Mr. Bradsher’s portfolio. The largest investments include STAAR Surgical Co and Monster Beverage, together worth $679 million.
$867 million Assets Under Management (AUM)
As of 7th October 2020, Broadwood Capital Inc’s top holding is 10,840,630 shares of STAAR Surgical Co currently worth over $381 million and making up 44.0% of the portfolio value.
Relative to the number of outstanding shares of STAAR Surgical Co, Broadwood Capital Inc owns more than 0.2% of the company.
In addition, the fund holds 4,679,308 shares of Monster Beverage worth $297 million, whose value grew 29.6% in the past six months.
The third-largest holding is Ishares Tr worth $69.6 million and the next is Axon Enterprise worth $55.7 million, with 760,062 shares owned.
Currently, Broadwood Capital Inc's portfolio is worth at least $867 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Broadwood Capital Inc
The Broadwood Capital Inc office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Neal Bradsher serves as the President at Broadwood Capital Inc.
Recent trades
In the most recent 13F filing, Broadwood Capital Inc revealed that it had increased its stake in OncoCyte and bought 1,176,471 additional shares worth around $2 million. This means they effectively own 0.2% of the company. OncoCyte makes up 6.7% of the fund's Health Care sector allocation and has decreased its share price by 13.1% in the past year.
One of the average hedge funds
The two most similar investment funds to Broadwood Capital Inc are Cacti Asset Management and Point72 Hong Kong Ltd. They manage $867 million and $869 million respectively.
Neal Bradsher investment strategy
Broadwood Capital Inc’s portfolio is diversified across 4 sectors.
Currently, their heaviest sector is Health Care — making up 47.8% of
the total portfolio value.
The fund focuses on investments in the United States as
71.4% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
29% of the total holdings value.
On the other hand, large-cap stocks make up 14.3% of the portfolio.
The average market cap of the portfolio companies is close to $10.2 billion.
The complete list of Broadwood Capital Inc trades based on 13F SEC filings
These positions were updated on February 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| STAAR Surgical Co. |
No change
10,840,630
|
$381,265,000 | 43.96% |
| Monster Beverage Corp. |
No change
4,679,308
|
$297,370,000 | 34.29% |
| Ishares Tr |
No change
420,000
|
$69,581,000 | 8.02% |
| Axon Enterprise, Inc. |
No change
760,062
|
$55,697,000 | 6.42% |
| Lineage Cell Therapeutics In |
No change
34,005,379
|
$30,265,000 | 3.49% |
| OncoCyte Corp. |
10.60%
12,274,738
|
$27,618,000 | 3.18% |
| AgeX Therapeutics, Inc. |
No change
2,997,156
|
$5,455,000 | 0.63% |
| No transactions found | |||
| Showing first 500 out of 7 holdings | |||
Hedge funds similar to Broadwood Capital Inc
- Goelzer Investment Management
- Portolan Capital Management
- Livforsakringsbolaget Skandia, Omsesidigt
- Cooperman Leon G
- Connecticut Wealth Management
- Corda Investment Management,
- Point72 Hong Kong Ltd
- Cacti Asset Management
- Lateef Investment Management, L.P.
- Venrock Management Vi
- Anglepoint Asset Management, Ltd
- Westwood Global Investments
- Oldfield Partners LL.P.
- Capital Growth Management L.P.